Huntsville Breast Cancer Survivors to Join Ribbon Run
Two breast cancer survivors will participate in the annual run to highlight the importance of persistent screening.
Updated on Oct. 16, 2026 in Cancer
Mother and daughter Shirley and Tonia Osieczanek will participate in the 23rd annual Liz Hurley Ribbon Run in Huntsville this Saturday, October 17, 2026. Both women are breast cancer survivors who have navigated distinct diagnostic and treatment paths.
Why it matters
The Osieczaneks’ experience highlights the importance of persistent screening, as Tonia’s cancer was caught by an optional MRI following a clear mammogram. Their story emphasizes that breast cancer can be detected through multiple modalities even when prior standard screenings appear normal.
This case report reflects clinical outcomes in two breast cancer patients, one diagnosed in 2006 and the other in 2024. While medical testing confirmed the conditions were not genetic, the diagnostic history remains limited to these two specific clinical instances.
The players
Shirley Osieczanek
A breast cancer survivor diagnosed at age 60 who has been cancer-free for nearly two decades.
Tonia Osieczanek
A breast cancer survivor diagnosed with Stage 1 disease in 2024 who underwent surgical and radiation treatment.
The details
Shirley Osieczanek’s cancer was detected after she identified a lump, leading to a biopsy and subsequent surgery, chemotherapy, and radiation. Tonia Osieczanek’s cancer was identified by an optional MRI with contrast after a clear 3D mammogram showed no issues. Tonia subsequently underwent surgery in December 2024 followed by a six-week course of radiation therapy.
Timeline
Shirley Osieczanek was diagnosed with breast cancer in 2006.
Shirley Osieczanek has been cancer-free since 2008.
Tonia Osieczanek received a clear 3D mammogram in October 2024.
Tonia Osieczanek underwent surgery on December 24, 2024.
The Ribbon Run takes place on October 17, 2026.
Health Landscape
Breast cancer care continues to evolve through the integration of supplemental imaging for patients where standard mammography may not provide sufficient clarity. This approach reflects a broader shift toward personalized diagnostic paths that account for individual risk factors beyond standard population-level screening protocols.
If you have concerns about your breast health, discuss the potential utility of supplemental screenings like MRIs with your physician, especially if you have dense breast tissue. Routine checkups remain the primary way to detect changes, but do not hesitate to ask about further imaging if you identify new symptoms.
The takeaway
Breast cancer screening can be a multi-layered process, and a clear mammogram does not always rule out a suspicious mass. If you notice persistent changes in your breast tissue, consult a physician immediately to determine if further testing or imaging is warranted for your specific situation.
Further reading
Learn more about advancements in screening and support at Cancer.
Source note: This article includes information reported by Waff.
